GIMBHI’s daily mental health update — 3/18/26

🚀 Andy Dunn, Bonobos co-founder, joins Sway Health as investor and advisor (LinkedIn) — 18/03/26
TL;DR: Andy Dunn, who wrote openly about living with bipolar disorder in his memoir Burn Rate, has joined Sway Health, the only virtual care platform dedicated exclusively to bipolar disorder - as an investor and advisor, backing a company serving ~10M underserved Americans.

🧠 Bliss raises $270K to build culturally intelligent AI for therapy (Tech.eu) — 11/03/26
TL;DR: Albanian-Finnish startup Bliss raised $270K in angel funding led by Keiretsu Forum, Finest Love VC, and Plug and Play to develop AI infrastructure for culturally aware therapy, combining licensed therapists across 10+ countries with AI-powered cultural and linguistic matching for diaspora communities.

😴 Pitt spinout Noctem lands $1.4M for remote insomnia treatment monitoring (Technical.ly) — 09/03/26
TL;DR: Pittsburgh-based Noctem Health, a Pitt spinout offering remote monitoring tools for insomnia treatment, raised $1.46M in equity funding from 12 investors to accelerate commercial growth, helping healthcare providers deliver personalized, evidence-based sleep care.

🧠 Mave Health raises $2.1M for brain-stimulating headset improving attention and mood (TechCrunch) — 18/03/26
TL;DR: San Francisco-based Mave Health raised $2.1M in seed funding led by Blume Ventures for its $495 tDCS neuromodulation headset, positioned as a non-medical lifestyle device claiming to improve focus, mood, and stress, with first shipments planned for April 2026.

🤖 Nature Medicine study shows Limbic’s AI outperforms therapists on cognitive behavioral therapy (Business Wire) — 12/03/26
TL;DR: A randomized, double-blind study published in Nature Medicine found Limbic’s clinical reasoning layer transformed general-purpose LLMs into CBT specialists, with 74.3% of AI sessions scoring higher than the top 10% of human therapy sessions and a 51.7% recovery rate in real-world deployment.

📊 First peer-reviewed Grow Therapy study finds meaningful improvements in depression and anxiety (Newswise) — 17/03/26
TL;DR: A large-scale study of 200,000+ adults published in JMIR Formative Research found about 59% achieved clinically meaningful improvement in depression and 63% in anxiety, with nearly 70% continuing beyond early sessions - far above the industry average of 37–45%.

🩺 Lyra Health launches toolkit offering mental health support for chronic conditions (Lyra Health) — 12/03/26
TL;DR: Lyra Health released its Health Challenges Toolkit, a personalized resource within its platform providing guided mental health support for people managing chronic pain, insomnia, cancer survivorship, and weight management, available worldwide.